The Oncology Institute, Inc. (TOI) News
Filter TOI News Items
TOI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TOI News Highlights
- TOI's 30 day story count now stands at 2.
- Over the past 16 days, the trend for TOI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about TOI are DEC and NOTE.
Latest TOI News From Around the Web
Below are the latest news stories about ONCOLOGY INSTITUTE INC that investors may wish to consider to help them evaluate TOI as an investment opportunity.
Insider Spends US$127k Buying More Shares In Oncology InstituteInvestors who take an interest in The Oncology Institute, Inc. ( NASDAQ:TOI ) should definitely note that the Chief... |
The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in CaliforniaCERRITOS, Calif, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (TOI) announced today that it has started operations of its first pharmacy in California after receiving approval from the California State Board of Pharmacy. This new service allows TOI to fill not only critical specialty medications and chemotherapeutics for MediCal patients, but also to provide medication fill capabilities to other patient populations. Located in the Los Angeles area, this new pharmacy location co |
Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI)In a notable insider transaction, Director Brad Hively has parted with 47,000 shares of The Oncology Institute Inc (NASDAQ:TOI), a significant move that warrants a closer look by investors and market analysts. |
Even With A 49% Surge, Cautious Investors Are Not Rewarding The Oncology Institute, Inc.'s (NASDAQ:TOI) Performance CompletelyDespite an already strong run, The Oncology Institute, Inc. ( NASDAQ:TOI ) shares have been powering on, with a gain of... |
The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss WidensTOI Reaffirms Full Year 2023 Guidance Amidst Expansion and Operational Developments |
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 GuidanceCERRITOS, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and nine months ended September 30, 2023 and reaffirmed its full year 2023 guidance. Recent Operational Highlights: Opened our 70th clinic and added 5 physicians bringing our total provider count to 112We are live on Ambience, a tool that utilizes AI te |
Oncology Institute Decline Means Insider Profits Down To US$113kThe Oncology Institute, Inc. ( NASDAQ:TOI ) insiders who acquired shares over the previous 12 months, can probably... |
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference CallCERRITOS, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2023 financial results after the market close on Wednesday, November 8, 2023, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international calle |
The Oncology Institute Names Jeremy Castle as Chief Operations OfficerCERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, 2023. In this role, Mr. Castle leads enterprise field and central operations, pharmacy, real estate, and practice integration, playing a key role in driving TOI’s success as a public company. Mr. Castle joins TOI with over 15 years of oncology industry experience, and has a track record of driving g |
The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) SummitCERRITOS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (TOI) is excited to announce that multiple executives including CEO, Dr. Daniel Virnich, CMO, Dr. Yale Podnos, and other senior clinical leaders, will be participating in the Association for Value-Based Cancer Care (AVBCC) Summit. The 2023 AVBCC Summit features keynote speakers, interactive panel discussions, and informative sessions designed to foster collaboration, innovation and progress in the |